logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Windlas Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    543329
    INE0H5O01029
    215.4715093
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WINDLAS
    39.26
    2338.43
    EPS(TTM)
    Face Value()
    Div & Yield %:
    28.5
    5
    0.49
     
Palash Securities Ltd
Palash Securities reports consolidated net loss of Rs 2.22 crore in the June 2024 quarter
Aug 16,2024
Net Loss of Palash Securities reported to Rs 2.22 crore in the quarter ended June 2024 as against net loss of Rs 4.27 crore during the previous quarter ended June 2023. Sales declined 19.98% to Rs 6.49 crore in the quarter ended June 2024 as against Rs 8.11 crore during the previous quarter ended June 2023.

ParticularsQuarter Ended
Jun. 2024Jun. 2023% Var.
Sales6.498.11 -20
OPM %-38.21-67.08 -
PBDT-3.08-5.97 48
PBT-3.23-6.16 48
NP-2.22-4.27 48